Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention

JACC Cardiovasc Interv. 2022 Apr 25;15(8):807-809. doi: 10.1016/j.jcin.2022.02.048.

Authors

Francesco Franchi¹, Fabiana Rollini²

Affiliations

¹ Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA. Electronic address: francesco.franchi@jax.ufl.edu.
² Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.

PMID: 35450680
DOI: 10.1016/j.jcin.2022.02.048

No abstract available

Keywords: antiplatelet therapy; bleeding; discontinuation; surgery.

Publication types

Editorial
Comment

MeSH terms

Drug Therapy, Combination
Dual Anti-Platelet Therapy / adverse effects
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors* / adverse effects
Risk Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors